Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7 - Identification of a critical aromatic amino acid residue at position 33

被引:39
|
作者
Barre, Lydia
Fournel-Gigleux, Sylvie
Finel, Moshe
Netter, Patrick
Magdalou, Jacques
Ouzzine, Mohamed
机构
[1] Univ Nancy 1, CNRS, UMR 7561, Fac Med, F-54505 Vandoeuvre Les Nancy, France
[2] Univ Helsinki, Fac Pharm, Drug Discovery & Dev Technol Ctr, FIN-00014 Helsinki, Finland
关键词
site-directed mutagenesis; substrate specificity; UDP-glucuronosyltransferase; UGT2B4; UGT2B7;
D O I
10.1111/j.1742-4658.2007.05670.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human UDP-glucuronosyltransferase (UGT) isoforms UGT2B4 and UGT2B7 play a major role in the detoxification of bile acids, steroids and phenols. These two isoforms present distinct but overlapping substrate specificity, sharing common substrates such as the bile acid hyodeoxycholic acid (HDCA) and catechol-estrogens. Here, we show that in UGT2B4, substitution of phenylalanine 33 by leucine suppressed the activity towards HDCA, and impaired the glucuronidation of several substrates, including 4-hydroxyestrone and 17-epiestriol. On the other hand, the substrate specificity of the mutant UGT2B4F33Y, in which phenylalanine was replaced by tyrosine, as found at position 33 of UGT2B7, was similar to wild-type UGT2B4. In the case of UGT2B7, replacement of tyrosine 33 by leucine strongly reduced the activity towards all the tested substrates, with the exception of 17-epiestriol. In contrast, mutation of tyrosine 33 by phenylalanine exhibited similar or even somewhat higher activities than wild-type UGT2B7. Hence, the results strongly indicated that the presence of an aromatic residue at position 33 is important for the activity and substrate specificity of both UGT2B4 and UGT2B7.
引用
收藏
页码:1256 / 1264
页数:9
相关论文
共 29 条
  • [1] Stereoselective Glucuronidation of Propranolol in Human and Cynomolgus Monkey Liver Microsomes: Role of Human Hepatic UDP-Glucuronosyltransferase Isoforms, UGT1A9, UGT2B4 and UGT2B7
    Hanioka, Nobumitsu
    Hayashi, Keiko
    Shimizudani, Takeshi
    Nagaoka, Kenjiro
    Koeda, Akiko
    Naito, Shinsaku
    Narimatsu, Shizuo
    PHARMACOLOGY, 2008, 82 (04) : 293 - 303
  • [2] Homodimerization of UDP-glucuronosyltransferase 2B7 (UGT2B7) and identification of a putative dimerization domain by protein homology modeling
    Lewis, Benjamin C.
    Mackenzie, Peter I.
    Miners, John O.
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (12) : 2016 - 2023
  • [3] Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance
    Bhasker, CR
    McKinnon, W
    Stone, A
    Lo, ACT
    Kubota, T
    Ishizaki, T
    Miners, JO
    PHARMACOGENETICS, 2000, 10 (08): : 679 - 685
  • [4] Alteration of human UDP-glucuronosyltransferase UGT2B17 regio-specificity by a single amino acid substitution
    Dubois, SG
    Beaulieu, M
    Lévesque, E
    Hum, DW
    Bélanger, A
    JOURNAL OF MOLECULAR BIOLOGY, 1999, 289 (01) : 29 - 39
  • [5] Extensive Protein-Protein Interactions Involving UDP-glucuronosyltransferase (UGT) 2B7 in Human Liver Microsomes
    Fujiwara, Ryoichi
    Itoh, Tomoo
    DRUG METABOLISM AND PHARMACOKINETICS, 2014, 29 (03) : 259 - 265
  • [6] Glucuronidation of 1′-hydroxyestragole (1′-HE) by human UDP-glucuronosyltransferases UGT2B7 and UGT1A9
    Iyer, LV
    Ho, MN
    Shinn, WM
    Bradford, WW
    Tanga, MJ
    Nath, SS
    Green, CE
    TOXICOLOGICAL SCIENCES, 2003, 73 (01) : 36 - 43
  • [7] Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients
    Romero-Lorca, Alicia
    Novillo, Apolonia
    Gaibar, Maria
    Bandres, Fernando
    Fernandez-Santander, Ana
    PLOS ONE, 2015, 10 (07):
  • [8] Effect of UGT1A4, UGT2B7, UGT2B15, UGT2B17 and ABC1B polymorphisms on lamotrigine metabolism in Danish patients
    Petrenaite, Vaiva
    Ohman, Inger
    Jantzen, Frederik Peter Thal
    Ekstrom, Lena
    EPILEPSY RESEARCH, 2022, 182
  • [9] Glucosidation of hyodeoxycholic acid by UDP-glucuronosyltransferase 2B7
    Mackenzie, P
    Little, JM
    Radominska-Pandya, A
    BIOCHEMICAL PHARMACOLOGY, 2003, 65 (03) : 417 - 421
  • [10] Glucuronidation of catechols by human hepatic, gastric, and intestinal microsomal UDP-glucuronosyltransferases (UGT) and recombinant UGT1A6, UGT1A9, and UGT2B7
    Antonio, L
    Xu, J
    Little, JM
    Burchell, B
    Magdalou, J
    Radominska-Pandya, A
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 411 (02) : 251 - 261